Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BTX - Brooklyn ImmunoTherapeutics establishes research and development center in Cambridge

BTX - Brooklyn ImmunoTherapeutics establishes research and development center in Cambridge

Brooklyn ImmunoTherapeutics Inc.
Brooklyn ImmunoTherapeutics (BTX) announces that it has established a research and development center in Cambridge, Massachusetts, to pursue its mRNA-based gene editing and cellular therapies.Shares up nearly 5% premarket."Our new R&D facility will provide us with the ability to advance our research and development efforts," CEO Howard Federoff said.The company has also co-located with Factor Bioscience and Novellus Therapeutics, from which it has acquired an exclusive worldwide license to develop and commercialize certain cell-based therapies to treat cancer and rare blood disorders.

For further details see:

Brooklyn ImmunoTherapeutics establishes research and development center in Cambridge
Stock Information
Company Name: Brooklyn ImmunoTherapeutics Inc.
Stock Symbol: BTX
Market: NYSE
Website: biotimeinc.com
Menu
BTX BTX Quote BTX Short BTX News BTX Articles BTX Message Board
Get BTX Alerts

News, Short Squeeze, Breakout and More Instantly...